H40.043
Steroid responder, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Steroid responder, bilateral (ICD-10 code H40.043), refers to a condition where an individual shows a significant response to steroid therapy in both eyes. This condition is commonly associated with certain types of glaucoma, where intraocular pressure (IOP) responds notably to corticosteroid medications. Recognizing this response is crucial for managing eye health and preventing potential vision loss.
Causes & Symptoms
Clinical Causes: Prolonged use of corticosteroid medications, either topical or systemic Genetic predisposition to steroid sensitivity in eye tissues Underlying eye conditions that predispose to increased intraocular pressure, such as glaucoma Pre-existing health conditions that alter the eye's response to steroids
Key Symptoms: Elevated intraocular pressure detected during eye examinations No noticeable symptoms in some cases, especially in early stages Potential discomfort or mild eye redness in certain instances Progressive eye discoloration or changes in vision if pressure remains uncontrolled
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves comprehensive eye examinations, including tonometry to measure intraocular pressure, and reviewing the patient's medical history regarding steroid use. The eye care professional may also perform visual field tests and optic nerve assessments. Identifying a bilateral response involves testing both eyes and monitoring the pressure changes in each.
Treatment Protocols: Management strategies focus on controlling intraocular pressure to prevent optic nerve damage. Typical interventions include:
Clinical Advice & FAQs
Billing Guidance
Is H40.043 a billable ICD-10 code?
Yes, H40.043 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H40.043?
Clinical documentation must specify the nature of Steroid responder, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference